ACTA1 and Hepatic fibrosis: Consistently, liver fibrosis and hepatic stellate cell (HSC) activation induced by CCl4 were also significantly attenuated when preventively treated with CVC, as quantified by decreased fibrotic areas and protein levels of collagen I and αSMA (Figure 1A-B).